You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abscopal

Showing 26 - 50 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Radiotherapy, Immunology Trial in Ghent (Cyclophosphamide, Stereotactic body radiotherapy)

Withdrawn
  • Radiotherapy
  • Immunology
  • Ghent, Belgium
    University Hospital - Radiotherapy Department
Jul 7, 2021

NSCLC, NSCLC Trial in Switzerland (Durvalumab, Radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • NSCLC
  • Aarau, Switzerland
  • +12 more
Oct 17, 2022

Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • IRE plus checkpoint inhibitor
  • IRE plus Checkpoint Inhibitor plus CpG-ODN
  • (no location specified)
Sep 13, 2023

Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Durvalumab
  • +2 more
  • Phoenix, Arizona
  • +41 more
Jul 16, 2022

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Irreversible electroporation
  • +2 more
  • Køge, Denmark
    Zealand University Hospital
Jan 27, 2023

Advanced Solid Tumors, Lymphoma Trial in Sacramento (epacadostat, SD-101, Radiotherapy)

Completed
Has Results
  • Advanced Solid Tumors
  • Lymphoma
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 25, 2022

Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)

Recruiting
  • Metastatic Cancer
  • Keytruda Injectable Product
  • +4 more
  • Rochester, Michigan
    Ascension Providence Rochester Hospital
Jun 15, 2022

Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,

Completed
  • Metastatic Prostatic Adenocarcinoma
  • Opdivo Injectable Product
  • +3 more
  • Lancaster, California
  • +1 more
Jun 15, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Withdrawn
  • Anatomic Stage III Breast Cancer AJCC v8
  • +11 more
  • (no location specified)
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 6, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Stage IV NSCLC Trial in Palo Alto (Immunotherapy (physician's choice for standard of care immunotherapy), Image-guided Radiation

Active, not recruiting
  • Stage IV Non-Small Cell Lung Cancer
  • Immunotherapy (physician's choice for standard of care immunotherapy)
  • Image-guided Radiation Therapy
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 17, 2022

Basal Cell Carcinoma Trial in Cleveland (ALA, PDT)

Recruiting
  • Basal Cell Carcinoma
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Mar 2, 2022

Metastatic Melanoma Trial in Baltimore (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Stereotactic Body Radiation Therapy

Withdrawn
  • Metastatic Melanoma
  • Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
  • Stereotactic Body Radiation Therapy (SBRT)
  • Baltimore, Maryland
  • +1 more
Apr 7, 2021

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

Hepatocellular Carcinoma, Gastric Cancer Trial in Orange (Nivolumab Injectable Product, Trans-arterial tirapazamine

Recruiting
  • Hepatocellular Carcinoma
  • Gastric Cancer
  • Nivolumab Injectable Product
  • Trans-arterial tirapazamine embolization
  • Orange, California
    University of California, Irvine
Apr 13, 2022

Soft-tissue Sarcoma Trial in London (Compound 451238)

Active, not recruiting
  • Soft-tissue Sarcoma
  • Compound 451238
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Dec 14, 2021

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022